[HTML] sciencedirect.com

[HTML][HTML] A role of FDG-PET/CT for response evaluation in metastatic breast cancer?

MG Hildebrandt, M Naghavi-Behzad… - Seminars in Nuclear …, 2022 - Elsevier
Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …
被引用次数：30 相关文章
[PDF] researchgate.net

[PDF][PDF] A role of FDG-PET/CT for response evaluation in metastatic breast cancer?

M Naghavi-Behzad, M Vogsen - Semin Nucl Med - researchgate.net
The prognosis for women diagnosed with primary breast cancer is good, with a 5 year
overall survival (OS) of 90%, but when the breast cancer has metastasized, the prognosis …

A role of FDG-PET/CT for response evaluation in metastatic breast cancer?

MG Hildebrandt… - Seminars in nuclear …, 2022 - pubmed.ncbi.nlm.nih.gov
Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

A role of FDG-PET/CT for response evaluation in metastatic breast cancer?

MG Hildebrandt… - … in Nuclear Medicine, 2022 - portal.findresearcher.sdu.dk
Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

A role of FDG-PET/CT for response evaluation in metastatic breast cancer?

MG Hildebrandt, M Naghavi-Behzad… - Seminars in Nuclear …, 2022 - europepmc.org
Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …